[DRBHCOM] QoQ TTM Result on 31-Dec-2008 [#3]

Stock
[DRBHCOM] DRB-HICOM BHD
Announcement Date
26-Feb-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2009
Quarter
31-Dec-2008 [#3]
Profit Trend
QoQ- -13.98%
YoY- 180.94%
Quarter Report
Latest QR
Upcoming QR
DRBHCOM's Result
DRBHCOM's Financial Summary
View:
Show?
TTM Result
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Revenue 6,106,760 6,178,499 6,101,427 5,993,827 5,526,123 4,762,522 4,012,379 32.28%
PBT 192,997 211,487 774,943 893,434 992,036 962,645 376,073 -35.87%
Tax -57,849 -53,795 -49,562 -65,220 -43,991 -38,517 -24,344 77.98%
NP 135,148 157,692 725,381 828,214 948,045 924,128 351,729 -47.11%
-
NP to SH 94,554 94,836 660,507 760,137 883,655 865,831 292,395 -52.85%
-
Tax Rate 29.97% 25.44% 6.40% 7.30% 4.43% 4.00% 6.47% -
Total Cost 5,971,612 6,020,807 5,376,046 5,165,613 4,578,078 3,838,394 3,660,650 38.53%
-
Net Worth 4,238,370 4,188,275 2,995,009 2,645,989 3,443,262 3,506,550 2,911,675 28.41%
Dividend
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Div 34,825 34,825 169,142 169,579 169,579 184,680 50,363 -21.78%
Div Payout % 36.83% 36.72% 25.61% 22.31% 19.19% 21.33% 17.22% -
Equity
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Net Worth 4,238,370 4,188,275 2,995,009 2,645,989 3,443,262 3,506,550 2,911,675 28.41%
NOSH 1,935,329 1,930,080 1,393,027 1,213,756 1,006,801 1,007,629 1,007,500 54.46%
Ratio Analysis
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
NP Margin 2.21% 2.55% 11.89% 13.82% 17.16% 19.40% 8.77% -
ROE 2.23% 2.26% 22.05% 28.73% 25.66% 24.69% 10.04% -
Per Share
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
RPS 315.54 320.12 438.00 493.82 548.88 472.65 398.25 -14.36%
EPS 4.89 4.91 47.42 62.63 87.77 85.93 29.02 -69.45%
DPS 1.80 1.80 12.14 13.97 16.83 18.33 5.00 -49.36%
NAPS 2.19 2.17 2.15 2.18 3.42 3.48 2.89 -16.86%
Adjusted Per Share Value based on latest NOSH - 1,213,756
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
RPS 315.88 319.59 315.61 310.04 285.85 246.35 207.55 32.27%
EPS 4.89 4.91 34.17 39.32 45.71 44.79 15.12 -52.85%
DPS 1.80 1.80 8.75 8.77 8.77 9.55 2.61 -21.92%
NAPS 2.1924 2.1665 1.5492 1.3687 1.7811 1.8138 1.5061 28.41%
Price Multiplier on Financial Quarter End Date
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Date 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 -
Price 1.16 1.04 0.69 0.73 0.88 0.96 1.27 -
P/RPS 0.37 0.32 0.16 0.15 0.16 0.20 0.32 10.15%
P/EPS 23.74 21.17 1.46 1.17 1.00 1.12 4.38 208.24%
EY 4.21 4.72 68.72 85.79 99.74 89.51 22.85 -67.58%
DY 1.55 1.73 17.60 19.14 19.13 19.09 3.94 -46.27%
P/NAPS 0.53 0.48 0.32 0.33 0.26 0.28 0.44 13.19%
Price Multiplier on Announcement Date
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Date 26/11/09 28/08/09 28/05/09 26/02/09 26/11/08 29/08/08 29/05/08 -
Price 1.04 1.14 0.99 0.74 0.71 0.99 1.19 -
P/RPS 0.33 0.36 0.23 0.15 0.13 0.21 0.30 6.55%
P/EPS 21.29 23.20 2.09 1.18 0.81 1.15 4.10 199.56%
EY 4.70 4.31 47.89 84.63 123.62 86.80 24.39 -66.60%
DY 1.73 1.58 12.26 18.88 23.70 18.52 4.20 -44.60%
P/NAPS 0.47 0.53 0.46 0.34 0.21 0.28 0.41 9.52%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment